Literature DB >> 3031817

Visualization of viral clearance in the living animal.

E M Verdin, E Maratos-Flier, C R Kahn, J C Sodoyez, F Sodoyez-Goffaux, C J De Vos, S P Lynn, B N Fields.   

Abstract

The early events in viral dissemination via the bloodstream were identified by monitoring the fate of 123I-radiolabeled reovirus after it was injected intravenously in rats. Continuous scintillation camera imaging showed that reovirus serotypes 1 and 3 were cleared from the circulation in less than 10 minutes by specific and distinct target organs. Reovirus serotype 1 accumulated predominantly in the lungs and the liver, whereas serotype 3 accumulated in the liver and the spleen with very little virus uptake by the lungs. Incubation of reovirus serotype 1 with a monoclonal antibody directed against the viral hemagglutinin before injection totally inhibited the clearance of the virus by the lungs. Similar results were obtained when viruses biolabeled with 35S were used. These results demonstrate that viruses can be rapidly transported through the bloodstream to specific target organs and that the localization of the viruses depends on the interaction between specific viral surface components and the target organ.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3031817     DOI: 10.1126/science.3031817

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  8 in total

1.  Bio-distribution study of Reolysin® (pelareorep) through a single intravenous infusion in Sprague-Dawley rats.

Authors:  Romit Chakrabarty; Hue Tran; Iohann Boulay; Tanya Moran; Audrey Parenteau; Robert Tavcar; Maude Bigras; Allison Hagerman; Sarah Serl; Brad Thompson; Matt Coffey
Journal:  Invest New Drugs       Date:  2013-12       Impact factor: 3.850

2.  Uptake of reovirus serotype 1 by the lungs from the bloodstream is mediated by the viral hemagglutinin.

Authors:  E M Verdin; S P Lynn; B N Fields; E Maratos-Flier
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

3.  Synergism between hepatic injuries and a nonhepatotropic reovirus in mice. Enhanced hepatic infection and death.

Authors:  D A Piccoli; C L Witzleben; C J Guico; A Morrison; D H Rubin
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

Review 4.  The oncolytic virus, pelareorep, as a novel anticancer agent: a review.

Authors:  Romit Chakrabarty; Hue Tran; Giovanni Selvaggi; Allison Hagerman; Brad Thompson; Matt Coffey
Journal:  Invest New Drugs       Date:  2015-02-19       Impact factor: 3.850

5.  Scintigraphic distribution of 123 I labelled proinsulin, split conversion intermediates and insulin in rats.

Authors:  F Sodoyez-Goffaux; J C Sodoyez; M Koch; C J De Vos; B H Frank
Journal:  Diabetologia       Date:  1988-11       Impact factor: 10.122

6.  Reovirus infection in rat lungs as a model to study the pathogenesis of viral pneumonia.

Authors:  M J Morin; A Warner; B N Fields
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

Review 7.  Innate immune surveillance of the circulation: A review on the removal of circulating virions from the bloodstream.

Authors:  Stephanie E Ander; Frances S Li; Kathryn S Carpentier; Thomas E Morrison
Journal:  PLoS Pathog       Date:  2022-05-05       Impact factor: 7.464

Review 8.  Current understanding of reovirus oncolysis mechanisms.

Authors:  Matthew B Phillips; Johnasha D Stuart; Roxana M Rodríguez Stewart; Jameson Tl Berry; Bernardo A Mainou; Karl W Boehme
Journal:  Oncolytic Virother       Date:  2018-06-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.